Safety
-
Neurontin (gabapentin) capsules, tablets, and oral solution
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011
ADVERSE REACTIONS
Postmarketing and Other Experience
- breast enlargement
-
-







